Skip to content

Clinical trials

Phase 2 Respiratory Distress Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 2 Country / region: United States Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20053
20062
20082
20092
20103
20112
20122
20131
20142
20153
20171
20181
20192
202023
20219
20221
20232
20241
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated19
Recruiting8
Active, not recruiting5
Withdrawn5
Unknown status3
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Windtree Therapeutics6
PPD Development, LP4
University of Minnesota4
GlaxoSmithKline2
Johns Hopkins University2
Massachusetts General Hospital2
Mayo Clinic2
Michael A. Matthay2
The University of Texas Health Science Center, Houston2
University of Maryland, Baltimore2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome74
COVID-1923
Acute Lung Injury21
Coronavirus Infections8
Respiratory Insufficiency8
Pneumonia7
Severe Acute Respiratory Syndrome6
Cytokine Release Syndrome5
Sepsis5
Pneumonia, Viral3

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.